title: Extracellular superoxide dismutase regulates cardiac function and fibrosis.
abstract: Extracellular superoxide dismutase (EC-SOD) is an antioxidant that protects the heart from ischemia and the lung from inflammation and fibrosis. The role of cardiac EC-SOD under normal conditions and injury remains unclear. Cardiac toxicity, a common side effect of doxorubicin, involves oxidative stress. We hypothesize that EC-SOD is critical for normal cardiac function and protects the heart from oxidant-induced fibrosis and loss of function. C57BL/6 and EC-SOD-null mice were treated with doxorubicin, 15 mg/kg (i.p.). After 15 days, echocardiography was used to assess cardiac function. Left ventricle (LV) tissue was used to assess fibrosis and inflammation by staining, Western blot, and hydroxyproline analysis. At baseline, EC-SOD-null mice have LV wall thinning and increases in LV end diastolic dimensions compared to wild-type mice but have normal cardiac function. After doxorubicin, EC-SOD-null mice have decreases in fractional shortening not apparent in WT mice. Lack of EC-SOD also leads to increases in myocardial apoptosis and significantly more LV fibrosis and inflammatory cell infiltration. Administration of the metalloporphyrin AEOL 10150 abrogates the loss of cardiac function, and potentially fibrosis, associated with doxorubicin treatment in both wild-type and EC-SOD KO mice. EC-SOD is critical for normal cardiac morphology and protects the heart from oxidant-induced fibrosis, apoptosis, and loss of function. The antioxidant metalloporphyrin AEOL 10150 effectively protects cardiac function from doxorubicin-induced oxidative stress in vivo. These findings identify targets for the use of antioxidant agents in oxidant-induced cardiac fibrosis.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
authors.forename: Corrine R
authors.initials: CR
authors.lastname: Kliment
authors.forename: Hagir B
authors.initials: HB
authors.lastname: Suliman
authors.forename: Jacob M
authors.initials: JM
authors.lastname: Tobolewski
authors.forename: Crystal M
authors.initials: CM
authors.lastname: Reynolds
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Day
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Zhu
authors.forename: Charles F
authors.initials: CF
authors.lastname: McTiernan
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: McGaffin
authors.forename: Claude A
authors.initials: CA
authors.lastname: Piantadosi
authors.forename: Tim D
authors.initials: TD
authors.lastname: Oury
mesh_terms: D000818:Animals; D015153:Blotting, Western; D004317:Doxorubicin / Q000494:pharmacology; D004452:Echocardiography; D005260:Female; D005355:Fibrosis / Q000201:enzymology* / Q000235:genetics; D006321:Heart / Q000187:drug effects; D017379:Hypertrophy, Left Ventricular / Q000201:enzymology; D007150:Immunohistochemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress / Q000187:drug effects; D011897:Random Allocation; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
chemical_list: D004317:Doxorubicin; C499090:Sod3 protein, mouse; D013482:Superoxide Dismutase
references.citation: Free Radic Biol Med. 2006 Feb 15;40(4):601-7
references.pmid: 16458190
references.citation: Circulation. 2007 Jul 31;116(5):506-14
references.pmid: 17638931
references.citation: Biochem J. 1996 Jan 1;313 ( Pt 1):235-9
references.pmid: 8546689
references.citation: J Biol Chem. 2001 Dec 14;276(50):47266-76
references.pmid: 11579094
references.citation: Circulation. 2005 Aug 16;112(7):1047-53
references.pmid: 16087794
references.citation: Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2327-35
references.pmid: 12842815
references.citation: Free Radic Biol Med. 2003 Oct 1;35(7):763-71
references.pmid: 14583340
references.citation: Biochem J. 2005 Jan 15;385(Pt 2):427-32
references.pmid: 15362977
references.citation: Arch Biochem Biophys. 1999 Aug 15;368(2):421-8
references.pmid: 10441396
references.citation: J Biol Chem. 2004 Jul 30;279(31):32243-51
references.pmid: 15166218
references.citation: Biochem Biophys Res Commun. 1985 Jul 31;130(2):739-45
references.pmid: 2992484
references.citation: Cardiovasc Res. 2008 Jan;77(1):54-63
references.pmid: 18006469
references.citation: J Biol Chem. 2004 Apr 2;279(14):13705-10
references.pmid: 14736885
references.citation: Free Radic Biol Med. 2003 Aug 1;35(3):236-56
references.pmid: 12885586
references.citation: Am J Respir Cell Mol Biol. 1997 Oct;17(4):393-403
references.pmid: 9376114
references.citation: Genomics. 1994 Jul 1;22(1):162-71
references.pmid: 7959763
references.citation: J Clin Invest. 1999 Apr;103(7):1055-66
references.pmid: 10194479
references.citation: Hypertension. 2008 Jan;51(1):19-25
references.pmid: 17998475
references.citation: Int J Biochem Cell Biol. 2005 Dec;37(12):2466-71
references.pmid: 16087389
references.citation: Lab Invest. 1994 Jun;70(6):889-98
references.pmid: 8015293
references.citation: Biochim Biophys Acta. 1980 Jun 5;630(1):119-30
references.pmid: 6248123
references.citation: Free Radic Biol Med. 2006 Jun 15;40(12):2223-31
references.pmid: 16785036
references.citation: Circulation. 2004 Jan 6;109(1):59-65
references.pmid: 14662715
references.citation: Biochemistry. 1997 Sep 23;36(38):11293-7
references.pmid: 9333325
references.citation: Am J Pathol. 2008 Mar;172(3):583-91
references.pmid: 18245812
references.citation: Antioxid Redox Signal. 2008 Feb;10(2):261-8
references.pmid: 17961072
references.citation: Am J Respir Cell Mol Biol. 2004 Oct;31(4):432-9
references.pmid: 15256385
references.citation: Free Radic Biol Med. 2002 Oct 1;33(7):988
references.pmid: 12361808
references.citation: J Clin Invest. 2005 May;115(5):1221-31
references.pmid: 15841206
references.citation: Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6264-8
references.pmid: 7603981
references.citation: Cardiovasc Res. 2004 Jun 1;62(3):468-80
references.pmid: 15158139
references.citation: Free Radic Biol Med. 2008 Apr 1;44(7):1305-13
references.pmid: 18206658
references.citation: J Clin Invest. 2000 Aug;106(4):589-97
references.pmid: 10953034
references.citation: Biochem Pharmacol. 2004 Jan 1;67(1):77-85
references.pmid: 14667930
references.citation: Mol Cell Biochem. 2002 May-Jun;234-235(1-2):119-24
references.pmid: 12162424
references.citation: N Engl J Med. 1998 Sep 24;339(13):900-5
references.pmid: 9744975
references.citation: Biol Pharm Bull. 1998 Oct;21(10):1090-3
references.pmid: 9821816
references.citation: Arch Biochem Biophys. 1961 May;93:440-7
references.pmid: 13786180
references.citation: Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H914-20
references.pmid: 16840738
references.citation: J Biol Chem. 2009 Feb 6;284(6):3537-45
references.pmid: 19073610
references.citation: J Appl Physiol (1985). 2004 Nov;97(5):2006-13
references.pmid: 15298984
references.citation: J Biol Chem. 2008 Mar 7;283(10):6058-66
references.pmid: 18165226
references.citation: Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):573-80
references.pmid: 17236973
references.citation: Basic Res Cardiol. 1994 Sep-Oct;89(5):397-410
references.pmid: 7535519
references.citation: Circulation. 1996 Nov 1;94(9 Suppl):II412-7
references.pmid: 8901783
references.citation: Clin Chim Acta. 1992 Nov 30;212(3):89-102
references.pmid: 1477980
references.citation: Hum Mol Genet. 1994 Dec;3(12):2251-4
references.pmid: 7881430
references.citation: Histochem J. 1979 Jul;11(4):447-55
references.pmid: 91593
references.citation: Circ Res. 2008 Nov 21;103(11):1232-40
references.pmid: 18845810